PRODUCTS
SERVICES
The primary investment objective of the scheme is to seek to generate consistent returns bypredominantly investing in equity and equity related securities of pharmaceutical and healthcarecompanies.
1.90
6 yrs 2 m
0.5%
3,339.79 Crs
0.50% on or before 1M, Nil after 1M
Mid Growth
7.71
SIP 100 & Lumpsum 100
BSE HEALTH CARE - TRI
Chirag Dagli
Investors understand that their principal will be at very high risk